|
Market Cap (27-Jun) $652,846,656 (311th) |
Close (30-Jun) $1.55 |
Volume (30-Jun) 1,225,647 |
Shortsold (26-May) 74,619,255 (10.80%) (12th) |
|
52w High $1.67 |
52w Low $0.87 |
P/E 31.65 |
EPS 0.01 |
A news article has been posted about PolyNovo on the AFR. The article was published around , on 12 January 2021 at 11:02am.
The biotech said predicting sales trajectory in its key market is "challenging" with hospital capacity strained as COVID-19 cases surge.
Read ArticlePNV was $3.53 at the close of trade on 08 January 2021
| Recent Articles about ASX:PNV | |
|---|---|
| 20-Jun | 604 Page 1 of 4 Form 604 Corporations Act 2001 Section 671B ...
company-announcements.afr.com |
| 20-Jun | J.P. MORGAN SECURITIES AUSTRALIA LIMITED JPMORGAN ...
company-announcements.afr.com |
| 12-Jun | PolyNovo U.S. Pivotal Trial – Clinical Study Report Finalised & PMA ...
company-announcements.afr.com |
| 12-Jun | ASX Announcement Imugene Announces Board Enhancement - AFR
company-announcements.afr.com |
| 30-Apr | Updated Share Trading Policy - AFR
company-announcements.afr.com |
| 22-Apr | Appointment of Dr Marthe D'Ombrain as Chief Scientific Officer - AFR
company-announcements.afr.com |
| 22-Apr | Global Leaders - The Australian Financial Review - AFR
afr.com |
| 10-Apr | NOTICE RECEIVED UNDER SECTION 249D OF THE ... - AFR
company-announcements.afr.com |
| 6-Mar | Change of Director's Interest Notice - AFR
company-announcements.afr.com |
| 9-Feb | 1H FY26 Trading Result (unaudited) - AFR
company-announcements.afr.com |
| Tracked |
Find all articles about PolyNovo, including others on the AFR, on the media page.
You must be logged in to post a reply.
PolyNovo 